It was demonstrated in both human and rat prostate cancer that metformin is able to inhibit migration of prostate cancer cells and tumor invasion by decreasing COX-2 level and PGE2 production (Tong et al., 2017). The gene discussed is PTGER2; the disease is prostate carcinoma.